All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the ...

All seven independent directors of 23andMe resigned from the company's board Tuesday, a move that CEO Anne Wojcicki said left her "surprised and disappointed," according to a memo to employees.

Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its board resigned en masse Tuesday. The move is almost certainly the final ...

23andMe Holding Co. co-founder and Chief Executive Officer Anne Wojcicki told employees that she remains committed to taking the genetic testing company private following the resignation of its ...

Seven directors of 23andMe resigned from the genetic test company's board Tuesday amid co-founder and CEO Anne Wojcicki's attempt to buy out existing shareholders and take the company private.

Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.

DNA-testing company 23AndMe and its founder, Anne Wojcicki, aimed to revolutionize healthcare, bringing genetic tests into homes with just a tube of spit. WSJ takes a look at the factors that have ...

Bloomberg report highlighted that Anne Wojcicki reaffirmed her commitment to privatizing the company. 23andMe witnessed a significant decline in its valuation, once at $6 billion. The board said ...

Seven independent members of the company’s eight-person board resigned Tuesday, concluding that despite co-founder and CEO Anne Wojcicki’s expressed intention to take the company private ...

On Tuesday, the independent directors of the Board of 23andMe Holding Co. (NASDAQ:ME) sent a letter to Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of ...